Spiegelman Daniel K
- SEC CIK
- 0001238403
No open-market purchases or sales filed in the past year.
Current role at each company
- VTVT vTv Therapeutics Inc.Directoras of Jun 29, 2026
- MAZE Maze Therapeutics, Inc.Directoras of Jun 10, 2026
- SPRB Spruce Biosciences, Inc.Directoras of May 26, 2026
- KYTX Kyverna Therapeutics, Inc.Directoras of Jun 2, 2025
- MYGN Myriad Genetics IncDirectoras of Jun 7, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Spiegelman Daniel K as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MYGN Myriad Genetics Inc
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2024 (view filing) | Jun 3-4 | 1 day | Spiegelman Daniel KDirector | SSale | −7.58K | $22.05 | −$167.0K | −18.7%32.9K after | 2 lots10b5-1 |
| Jun 2, 2023 (view filing) | Jun 2 | Same day | Spiegelman Daniel KDirector | SSale | −8.64K | $23.01 | −$198.8K | −17.6%40.5K after | |
| Jun 6, 2022 (view filing) | Jun 6 | Same day | Spiegelman Daniel KDirector | SSale | −6.42K | $19.25 | −$123.7K | −15.9%34.0K after |